Phase I, First-In Human Study to Evaluate Safety and Tolerability of EuRSV in Healthy Adults Aged Between 19 Years and 80 Years

Phase 1 Active not recruiting 100 enrolled EuBiologics Co.,Ltd

RandomizedParallel-groupDouble-blindPrevention

Summary

Phase 1 clinical trial to evaluate the safety of RSV-1 and RSV-2 vaccines in healthy adults aged 19 to 80 years who have voluntarily given written consent to participate in this study.

Timeline

Start: 2024-05-08
Primary completion: 2025-07-31
Completion: 2025-09-30

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	EuRSV	Unknown	0.5 ml	Intramuscular

Phase I, First-In Human Study to Evaluate Safety and Tolerability of EuRSV in Healthy Adults Aged Between 19 Years and 80 Years

Summary

Timeline

Drugs

Indications